Montrouge, France, June 7, 2022
DBVTechnologies Announces Positive Topline Results fromPhase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers
Read more at globenewswire.comProvided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.